2 researched Pavilion Sales entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer Pear Therapeutics is not a 2026 revenue story—it's a post-bankruptcy IP acquisition play. Click Therapeutics (actual buyer) and a 2026 successor need to: (1) Pivot reSET, reSET-O, and Somryst from prescription-reimbursement (d…
Read full answer ↗Bottom line: Total Aviation's 2026 revenue fix is a 12-month journey from a commodity contingent staffing firm (18–24% margins, 40% client churn, reactive sourcing) to a vertical-specific retained-search powerhouse (32–38% margins, 80%+ cli…
Read full answer ↗